Kalman Filanovsky

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

Patrice Chevallier, Myriam Labopin, Pascal Turlure et al. · Leukemia · 2011 · 121 citations

Hematological Malignancy, Prognostic Evaluation, Medicine +10

Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

Drorit Merkel, Kalman Filanovsky, Anat Gafter‐Gvili et al. · American Journal of Hematology · 2012 · 67 citations · Full text

Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience

Yafit Segman, Elena Ribakovsky, Abraham Avigdor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 35 citations

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim <scp>PET</scp>/<scp>CT</scp> is beneficial: a prospective multicentre trial of 355 patients

Eldad J. Dann, Osnat Bairey, Rachel Bar‐Shalom et al. · British Journal of Haematology · 2017 · 33 citations · Full text

Higher Infection Rate After 7- Compared With 5-Day Cycle of Azacitidine in Patients With Higher-Risk Myelodysplastic Syndrome

Yishai Ofran, Kalman Filanovsky, Anat Gafter‐Gvili et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 22 citations

Hematological Malignancy, Higher-risk Myelodysplastic Syndrome, Hematology +4